Preface to DMR special edition 'Cannabinoid receptors and ligands: therapeutic drug development and abuse potential'.
作者信息
Prather Paul L
机构信息
a Department of Pharmacology and Toxicology, College of Medicine , University of Arkansas for Medical Sciences , Little Rock , AR , USA.
出版信息
Drug Metab Rev. 2018 Feb;50(1):1-2. doi: 10.1080/03602532.2018.1431657. Epub 2018 Jan 30.
Abstract
摘要
相似文献
1
Preface to DMR special edition 'Cannabinoid receptors and ligands: therapeutic drug development and abuse potential'.《药物代谢与处置》特刊“大麻素受体与配体：治疗药物研发及滥用潜力”前言
Drug Metab Rev. 2018 Feb;50(1):1-2. doi: 10.1080/03602532.2018.1431657. Epub 2018 Jan 30.
2
Metabolically labile cannabinoid esters: a 'soft drug' approach for the development of cannabinoid-based therapeutic drugs.代谢不稳定的大麻素酯：一种开发基于大麻素的治疗药物的“软药”方法。
Bioorg Med Chem Lett. 2007 Sep 1;17(17):4878-81. doi: 10.1016/j.bmcl.2007.06.055. Epub 2007 Jun 20.
3
A new dawn in cannabinoid neurobiology: The road from molecules to therapeutic discoveries.大麻素神经生物学的新曙光：从分子到治疗发现之路。
Neuropharmacology. 2017 Sep 15;124:1-2. doi: 10.1016/j.neuropharm.2017.07.004. Epub 2017 Jul 8.
4
Cannabinoids and their actions.大麻素及其作用。
Br J Pharmacol. 2007 Nov;152(5):557-8. doi: 10.1038/sj.bjp.0707483. Epub 2007 Sep 24.
5
Recent progress in cannabinoid research.大麻素研究的最新进展。
Prog Med Chem. 2006;44:207-329. doi: 10.1016/S0079-6468(05)44406-9.
6
Neurochemical basis of cannabis addiction.大麻成瘾的神经化学基础。
Neuroscience. 2011 May 5;181:1-17. doi: 10.1016/j.neuroscience.2011.02.035. Epub 2011 Feb 18.
7
Cannabinoids as potential anti-epileptic drugs.大麻素作为潜在的抗癫痫药物。
Curr Opin Investig Drugs. 2005 Jul;6(7):680-5.
8
Recent developments in cannabinoid ligands.
Life Sci. 2005 Aug 19;77(14):1767-98. doi: 10.1016/j.lfs.2005.05.020.
9
Cannabinoids, endogenous ligands and synthetic analogs.大麻素、内源性配体及合成类似物。
Curr Opin Chem Biol. 1999 Aug;3(4):418-25. doi: 10.1016/S1367-5931(99)80062-3.
10
Focus on cannabinoids and synthetic cannabinoids.关注大麻素和合成大麻素。
Clin Pharmacol Ther. 2017 Feb;101(2):220-229. doi: 10.1002/cpt.563. Epub 2016 Dec 20.
本文引用的文献
1
Phytocannabinoids: a unified critical inventory.植物大麻素：统一的关键清单。
Nat Prod Rep. 2016 Nov 23;33(12):1357-1392. doi: 10.1039/c6np00074f.
2
Cannabinoids in the Treatment of Epilepsy.大麻素在癫痫治疗中的应用
N Engl J Med. 2015 Sep 10;373(11):1048-58. doi: 10.1056/NEJMra1407304.
3
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.神经退行性疾病和中风/脑外伤中的大麻素：从临床前模型到临床应用
Neurotherapeutics. 2015 Oct;12(4):793-806. doi: 10.1007/s13311-015-0381-7.
4
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials.大麻素治疗慢性非癌性疼痛：随机对照试验的更新系统评价。
J Neuroimmune Pharmacol. 2015 Jun;10(2):293-301. doi: 10.1007/s11481-015-9600-6. Epub 2015 Mar 22.
5
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?与 Δ(9)-THC 相比，K2 合成大麻素具有独特的药理学和代谢：毒性更大的潜在机制？
Life Sci. 2014 Feb 27;97(1):45-54. doi: 10.1016/j.lfs.2013.09.017. Epub 2013 Sep 29.
6
Blurred boundaries: the therapeutics and politics of medical marijuana.模糊的界限：医用大麻的治疗功效和政治影响。
Mayo Clin Proc. 2012 Feb;87(2):172-86. doi: 10.1016/j.mayocp.2011.10.003.
7
Regulation of nausea and vomiting by cannabinoids.大麻素对恶心和呕吐的调节。
Br J Pharmacol. 2011 Aug;163(7):1411-22. doi: 10.1111/j.1476-5381.2010.01176.x.
8
Plant, synthetic, and endogenous cannabinoids in medicine.医学中的植物性、合成性和内源性大麻素。
Annu Rev Med. 2006;57:553-74. doi: 10.1146/annurev.med.57.011205.135648.
9
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.低剂量口服大麻素疗法可减缓小鼠动脉粥样硬化的进展。
Nature. 2005 Apr 7;434(7034):782-6. doi: 10.1038/nature03389.
10
Cannabinoids: potential anticancer agents.大麻素：潜在的抗癌药物。
Nat Rev Cancer. 2003 Oct;3(10):745-55. doi: 10.1038/nrc1188.
Zotero 插件